Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients

Rhianna Miles1, Carmel M Hawley, Stephen P McDonald

  • 1Australia and New Zealand Dialysis and Transplant Registry, Adelaide, Australia.

Kidney International
|June 12, 2009
PubMed

Insights

Fungal peritonitis, a serious complication of peritoneal dialysis, is linked to indigenous race and prior bacterial peritonitis treatment. Prompt catheter removal and antifungal therapy reduce risks of recurrence and death.

Area of Science:

  • Nephrology
  • Infectious Diseases
  • Public Health

Background:

  • Fungal peritonitis is a severe complication of peritoneal dialysis (PD).
  • Previous research on fungal peritonitis is limited to small, single-center studies.
  • This study utilizes a comprehensive national dataset to investigate fungal peritonitis in PD patients.

Purpose of the Study:

  • To identify predictors of fungal peritonitis in Australian PD patients.
  • To examine treatments and outcomes associated with fungal peritonitis.
  • To compare the effectiveness of different interventions for fungal peritonitis.

Main Methods:

  • Analysis of data from all Australian PD centers over a 4-year period.
  • Inclusion of 162 episodes of fungal peritonitis in 158 individuals.
  • Statistical analysis using logistic regression and multilevel, multivariate Poisson regression.

Main Results:

  • Candida species were the most common fungi identified (69%).
  • Indigenous race and prior bacterial peritonitis treatment were independent predictors.
  • Fungal peritonitis correlated with increased hospitalization, catheter removal, hemodialysis transfer, and mortality.
  • Combined catheter removal and antifungal therapy yielded the lowest risks for recurrence and death.

Conclusions:

  • Fungal peritonitis is a significant complication of PD with poor outcomes.
  • Recent antibiotic treatment for bacterial peritonitis warrants strong suspicion for fungal peritonitis.
  • Optimal management involves catheter removal and antifungal therapy to minimize adverse outcomes.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
Peritoneal Dialysis I: Introduction and Procedure01:30

Peritoneal Dialysis I: Introduction and Procedure

Peritoneal dialysis (PD) is a procedure that facilitates the exchange of solutes, waste products, electrolytes, and excess fluid between the blood in the peritoneal capillaries and a dialysis solution introduced into the peritoneal cavity.Principles of Peritoneal Dialysis (PD)Diffusion: Waste products such as urea and electrolytes move from high concentrations in the blood to low concentrations in the dialysate across the peritoneal membrane. This mechanism is driven by the concentration...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...